Inflammation and Cardiovascular Disease Risk: A Case Study of HIV and Inflammatory Joint Disease

Faisal Rahman, Seth Martin, Seamus Whelton, Freny V. Mody, Joban Vaishnav, John William McEvoy

Research output: Contribution to journalArticle

Abstract

The epidemiologic data associating infection and inflammation with increased risk of cardiovascular disease is well established. Patients with chronically upregulated inflammatory pathways, such as those with HIV and inflammatory joint diseases, often have a risk of future cardiovascular risk that is similar to or higher than patients with diabetes. Thus, it is of heightened importance for clinicians to consider the cardiovascular risk of patients with these conditions. HIV and inflammatory joint diseases are archetypal examples of how inflammatory disorders contribute to vascular disease and provide illustrative lessons that can be leveraged in the prevention of cardiovascular disease. Managing chronic inflammatory diseases calls for a multifaceted approach to evaluation and treatment of suboptimal lifestyle habits, accurate estimation of cardiovascular disease risk with potential upwards recalibration due to chronic inflammation, and more intensive treatment of risk factors because current tools often underestimate the risk in this population. This approach is further supported by the recently published CANTOS trial demonstrating that reducing inflammation can serve as a therapeutic target among persons with residual inflammatory risk for cardiovascular disease.

Original languageEnglish (US)
JournalAmerican Journal of Medicine
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Joint Diseases
Cardiovascular Diseases
HIV
Inflammation
Vascular Diseases
Habits
Life Style
Chronic Disease
Therapeutics
Infection
Population

Keywords

  • Cardiovascular disease
  • Human immunodeficiency virus
  • Inflammatory joint diseases
  • Prevention
  • Risk

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Inflammation and Cardiovascular Disease Risk : A Case Study of HIV and Inflammatory Joint Disease. / Rahman, Faisal; Martin, Seth; Whelton, Seamus; Mody, Freny V.; Vaishnav, Joban; McEvoy, John William.

In: American Journal of Medicine, 01.01.2018.

Research output: Contribution to journalArticle

@article{3cbcb47b16b84a3db15805395113f29e,
title = "Inflammation and Cardiovascular Disease Risk: A Case Study of HIV and Inflammatory Joint Disease",
abstract = "The epidemiologic data associating infection and inflammation with increased risk of cardiovascular disease is well established. Patients with chronically upregulated inflammatory pathways, such as those with HIV and inflammatory joint diseases, often have a risk of future cardiovascular risk that is similar to or higher than patients with diabetes. Thus, it is of heightened importance for clinicians to consider the cardiovascular risk of patients with these conditions. HIV and inflammatory joint diseases are archetypal examples of how inflammatory disorders contribute to vascular disease and provide illustrative lessons that can be leveraged in the prevention of cardiovascular disease. Managing chronic inflammatory diseases calls for a multifaceted approach to evaluation and treatment of suboptimal lifestyle habits, accurate estimation of cardiovascular disease risk with potential upwards recalibration due to chronic inflammation, and more intensive treatment of risk factors because current tools often underestimate the risk in this population. This approach is further supported by the recently published CANTOS trial demonstrating that reducing inflammation can serve as a therapeutic target among persons with residual inflammatory risk for cardiovascular disease.",
keywords = "Cardiovascular disease, Human immunodeficiency virus, Inflammatory joint diseases, Prevention, Risk",
author = "Faisal Rahman and Seth Martin and Seamus Whelton and Mody, {Freny V.} and Joban Vaishnav and McEvoy, {John William}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.amjmed.2017.11.034",
language = "English (US)",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Inflammation and Cardiovascular Disease Risk

T2 - A Case Study of HIV and Inflammatory Joint Disease

AU - Rahman, Faisal

AU - Martin, Seth

AU - Whelton, Seamus

AU - Mody, Freny V.

AU - Vaishnav, Joban

AU - McEvoy, John William

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The epidemiologic data associating infection and inflammation with increased risk of cardiovascular disease is well established. Patients with chronically upregulated inflammatory pathways, such as those with HIV and inflammatory joint diseases, often have a risk of future cardiovascular risk that is similar to or higher than patients with diabetes. Thus, it is of heightened importance for clinicians to consider the cardiovascular risk of patients with these conditions. HIV and inflammatory joint diseases are archetypal examples of how inflammatory disorders contribute to vascular disease and provide illustrative lessons that can be leveraged in the prevention of cardiovascular disease. Managing chronic inflammatory diseases calls for a multifaceted approach to evaluation and treatment of suboptimal lifestyle habits, accurate estimation of cardiovascular disease risk with potential upwards recalibration due to chronic inflammation, and more intensive treatment of risk factors because current tools often underestimate the risk in this population. This approach is further supported by the recently published CANTOS trial demonstrating that reducing inflammation can serve as a therapeutic target among persons with residual inflammatory risk for cardiovascular disease.

AB - The epidemiologic data associating infection and inflammation with increased risk of cardiovascular disease is well established. Patients with chronically upregulated inflammatory pathways, such as those with HIV and inflammatory joint diseases, often have a risk of future cardiovascular risk that is similar to or higher than patients with diabetes. Thus, it is of heightened importance for clinicians to consider the cardiovascular risk of patients with these conditions. HIV and inflammatory joint diseases are archetypal examples of how inflammatory disorders contribute to vascular disease and provide illustrative lessons that can be leveraged in the prevention of cardiovascular disease. Managing chronic inflammatory diseases calls for a multifaceted approach to evaluation and treatment of suboptimal lifestyle habits, accurate estimation of cardiovascular disease risk with potential upwards recalibration due to chronic inflammation, and more intensive treatment of risk factors because current tools often underestimate the risk in this population. This approach is further supported by the recently published CANTOS trial demonstrating that reducing inflammation can serve as a therapeutic target among persons with residual inflammatory risk for cardiovascular disease.

KW - Cardiovascular disease

KW - Human immunodeficiency virus

KW - Inflammatory joint diseases

KW - Prevention

KW - Risk

UR - http://www.scopus.com/inward/record.url?scp=85041579010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041579010&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2017.11.034

DO - 10.1016/j.amjmed.2017.11.034

M3 - Article

C2 - 29269230

AN - SCOPUS:85041579010

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

ER -